Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Badger Meter
BMI
$4.04B
| $2.36M | ﹤0.01% |
23,710
-15,644
| -40% | -$1.53M |
|
1702
Murphy Oil
MUR
$5.17B
| $2.36M | ﹤0.01% |
58,408
-167,209
| -74% | -$5.73M |
|
|
ENPC
1703
DELISTED
Executive Network Partnering Corporation
ENPC
| $2.36M | ﹤0.01% |
+239,205
| New | +$2.35M |
|
1704
NBT Bancorp
NBTB
$2.77B
| $2.35M | ﹤0.01% |
64,962
-12,695
| -16% | -$493K |
|
1705
Federal Signal
FSS
$7.95B
| $2.34M | ﹤0.01% |
69,313
-38,878
| -36% | -$1.45M |
|
1706
Monro
MNRO
$411M
| $2.34M | ﹤0.01% |
52,724
+11,482
| +28% | +$560K |
|
1707
Westamerica Bancorp
WABC
$1.38B
| $2.34M | ﹤0.01% |
38,642
-11,286
| -23% | -$673K |
|
1708
Innospec
IOSP
$2.27B
| $2.33M | ﹤0.01% |
25,138
-19,750
| -44% | -$1.87M |
|
1709
Cornerstone Strategic Value Fund
CLM
$2.23B
| $2.33M | ﹤0.01% |
+254,000
| New | +$3.51M |
|
|
PACX
1710
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
| $2.33M | ﹤0.01% |
+236,968
| New | +$2.32M |
|
|
ILPT
1711
Industrial Logistics Properties Trust
ILPT
$584M
| $2.32M | ﹤0.01% |
102,406
+4,322
| +4% | +$98.7K |
|
1712
Varex Imaging
VREX
$522M
| $2.32M | ﹤0.01% |
108,967
+40,882
| +60% | +$1.04M |
|
1713
Andersons Inc
ANDE
$2.37B
| $2.32M | ﹤0.01% |
46,089
-18,569
| -29% | -$781K |
|
|
ITCI
1714
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.31M | ﹤0.01% |
37,832
-65,138
| -63% | -$3.38M |
|
|
DHR.PRA
1715
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $2.31M | ﹤0.01% |
1,140
+300
| +36% | +$569K |
|
1716
Independent Bank Corp
IBCP
$791M
| $2.3M | ﹤0.01% |
104,337
-16,135
| -13% | -$388K |
|
|
CCAI
1717
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
| $2.29M | ﹤0.01% |
+235,100
| New | +$2.29M |
|
1718
Forward Air
FWRD
$487M
| $2.29M | ﹤0.01% |
23,425
-11,622
| -33% | -$1.22M |
|
1719
Arcosa
ACA
$7.14B
| $2.29M | ﹤0.01% |
39,963
-24,602
| -38% | -$1.27M |
|
1720
MYR Group
MYRG
$5.2B
| $2.29M | ﹤0.01% |
24,322
-2,142
| -8% | -$204K |
|
|
PDCE
1721
DELISTED
PDC Energy, Inc.
PDCE
| $2.29M | ﹤0.01% |
31,420
-101,391
| -76% | -$6.27M |
|
1722
Wheaton Precious Metals
WPM
$55.8B
| $2.28M | ﹤0.01% |
47,980
+12,465
| +35% | +$542K |
|
1723
ARK Genomic Revolution ETF
ARKG
$1.66B
| $2.28M | ﹤0.01% |
49,605
+2,454
| +5% | +$117K |
|
1724
Relay Therapeutics
RLAY
$4.29B
| $2.28M | ﹤0.01% |
+76,068
| New | +$1.85M |
|
|
FFWM
1725
DELISTED
First Foundation Inc
FFWM
| $2.27M | ﹤0.01% |
93,459
-23,119
| -20% | -$601K |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.